Atıf İçin Kopyala
ŞAHİN F., SAYDAM G., Comert M., Uz B., Yavuz A. S., Turan E., ...Daha Fazla
TURKISH JOURNAL OF HEMATOLOGY, cilt.30, sa.4, ss.351-358, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
30
Sayı:
4
-
Basım Tarihi:
2013
-
Doi Numarası:
10.4274/tjh.2013.0151
-
Dergi Adı:
TURKISH JOURNAL OF HEMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.351-358
-
Anahtar Kelimeler:
Chronic myeloid leukemia, Registry, Response, CHRONIC MYELOGENOUS LEUKEMIA, CHRONIC-PHASE, IMATINIB, CYTARABINE, INTERFERON, SURVIVAL, TRIALS
-
Çukurova Üniversitesi Adresli:
Evet
Özet
Objective: here have been tremendous changes in treatment and follow-up of patients with chronic myeloid leukemia (CML) in the last decade. Especially, regular publication and updating of NCCN and ELN guidelines have provided enermous rationale and base for close monitorization of patients with CML. But, it is stil needed to have registry results retrospectively to evaluate daily CML practices.